Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics: A Postmortem Study

Objective—Coronary atherosclerotic plaque composition of diabetic subjects and localization of receptor for advanced glycation end products (RAGE) and its ligands have not been extensively studied. Method and Results—Hearts from diabetic subjects and age, race, and sex-matched nondiabetic subjects dying suddenly were examined. Coronary arteries were dissected and lesions were evaluated for plaque burden, necrotic core size, and inflammatory infiltrate. The expression of RAGE, the RAGE-binding protein (S100-A12, EN-RAGE), and cell death (apoptosis) were also determined. Lesions from type II diabetic subjects had larger mean necrotic cores (P= 0.01) and greater total and distal plaque load (P <0.001) than nondiabetic subjects. Necrotic core size correlated positively with diabetic status, independent of other risk factors. Intimal staining for macrophages, T-cells, and HLA-DR was also significantly greater in diabetic subjects (P =0.03, P =0.003, and P <0.0001), respectively. The association of increased macrophage infiltrate was independent of cholesterol levels and patient age. Expression of RAGE and EN-RAGE was significantly greater in diabetic subjects (P =0.004) and was associated with apoptotic smooth muscle cells and macrophages. Conclusion—In sudden coronary death, inflammation and necrotic core size play a greater role in the progression of atherosclerosis in diabetic subjects. The expression of RAGE and EN-RAGE may further compromise cell survival and promote plaque destabilization.

[1]  M. Alessi,et al.  Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis , 1991, Diabetologia.

[2]  W. Nacken,et al.  Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction. , 2003, Trends in immunology.

[3]  J. Hokanson,et al.  Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. , 2003, Diabetes.

[4]  Y. Tomer,et al.  The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. , 2003, Autoimmunity reviews.

[5]  R. Muraro,et al.  The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques: Role of Glycemic Control , 2003, Circulation.

[6]  P. Rouleau,et al.  The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. , 2003, Clinical immunology.

[7]  T. Kislinger,et al.  RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice , 2002, Circulation.

[8]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[9]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[10]  R. Virmani,et al.  Traditional Risk Factors and the Incidence of Sudden Coronary Death With and Without Coronary Thrombosis in Blacks , 2002, Circulation.

[11]  Renu Virmani,et al.  Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis , 2002, Circulation.

[12]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[13]  Renu Virmani,et al.  Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.

[14]  I. Chernushevich,et al.  Total chemical synthesis and chemotactic activity of human S100A12 (EN‐RAGE) , 2001, FEBS letters.

[15]  Z. Makita,et al.  Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease , 2001, Brain Research.

[16]  M. Rubens,et al.  The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. , 2000, Journal of the American College of Cardiology.

[17]  R. Virmani,et al.  Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. , 2000, The American journal of pathology.

[18]  V. D’Agati,et al.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. , 2000, Journal of the American Society of Nephrology : JASN.

[19]  K. Kawasaki,et al.  Roles of the AGE‐RAGE System in Vascular Injury in Diabetes a , 2000, Annals of the New York Academy of Sciences.

[20]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Virmani,et al.  Arterial remodeling in the left coronary system: the role of high-density lipoprotein cholesterol. , 1999, Journal of the American College of Cardiology.

[22]  N. Weissman,et al.  Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling. , 1999, The American journal of cardiology.

[23]  D Glogar,et al.  Coronary risk factors influence plaque morphology in patients with unstable angina. , 1999, Coronary artery disease.

[24]  P. Weston,et al.  Sudden death in type 1 diabetes , 1999, Diabetes, obesity & metabolism.

[25]  H. Sano,et al.  Receptors for proteins modified by advanced glycation endproducts (AGE)—their functional role in atherosclerosis , 1999, Mechanisms of Ageing and Development.

[26]  H. Mcgill,et al.  Determinants of atherosclerosis in the young , 1998 .

[27]  R. Virmani,et al.  Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. , 1998, Circulation.

[28]  M. Leon,et al.  Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. , 1998, The American journal of cardiology.

[29]  R. Bucala,et al.  Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. , 1997, Metabolism: clinical and experimental.

[30]  R. Virmani,et al.  Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.

[31]  T. Ivert,et al.  Comparison of early and late mortality in men and women after isolated coronary artery bypass graft surgery in Stockholm, Sweden, 1980 to 1989. , 1997, Journal of the American College of Cardiology.

[32]  M. Matsumoto,et al.  Rage: A Novel Cellular Receptor for Advanced Glycation End Products , 1996, Diabetes.

[33]  C. White,et al.  Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. , 1995, Circulation.

[34]  J. Strong,et al.  Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[35]  G. Comi,et al.  Normal Tissue Plasminogen Activator and Plasminogen Activator Inhibitor Activity in Plasma from Patients with Type 1 Diabetes Mellitus , 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[36]  R. Bucala,et al.  Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.